|
Sudeep Pharma Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
12487.04 Cr.
|
P/BV
|
14.14
|
Book Value (Rs.)
|
78.21
|
|
52 Week High/Low (Rs.)
|
1159/524
|
FV/ML
|
1/1
|
P/E(X)
|
72.22
|
|
Bookclosure
|
23/07/2026
|
EPS (Rs.)
|
15.31
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 354.67 | 287.58 |
| Total Income From Operations | 354.67 | 287.58 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 141.40 | 128.10 |
| Increase/Decrease in Stocks | -17.35 | -24.85 |
| Employees Cost | 25.56 | 26.33 |
| Depreciation | 7.75 | 7.06 |
| Other Expenses | 82.50 | 58.66 |
| Total Expenses | 239.85 | 195.31 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 114.82 | 92.27 |
| Other Income | 13.26 | 15.32 |
| P/L Before Interest, Excpt. Items & Tax | 128.08 | 107.60 |
| Interest | 3.61 | 3.99 |
| P/L Before Exceptional Items & Tax | 124.47 | 103.61 |
| P/L Before Tax | 124.47 | 103.61 |
| Tax | 28.23 | 25.56 |
| P/L After Tax from Ordinary Activities | 96.24 | 78.05 |
| Net Profit/Loss For the Period | 96.24 | 78.05 |
| Minority Interest | 0.10 | -1.49 |
| Net P/L After Minority Interest & Share Of Associates | 96.34 | 76.55 |
| | | |
| Equity Share Capital | 11.29 | 9.72 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 8.52 | 7.05 |
| Diluted EPS (Rs.) | 8.52 | 7.05 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 8.52 | 7.05 |
| Diluted EPS (Rs.) | 8.53 | 7.05 |
| | | |
| PBITOE Margin (%) | 32.37 | 32.08 |
| PBTE Margin (%) | 35.09 | 36.02 |
| PBT Margin (%) | 35.09 | 36.02 |
| PAT Margin (%) | 27.13 | 27.13 |
| PAT After MI And SOA Margin (%) | 27.16 | 26.61 |
